Top Markets
#1 PulseChain PulseChain +45.01%
#2 SkyAI SkyAI +12.67%
#3 Meteora Meteora +11.24%
#4 Glidr Glidr +9.27%
#5 OPENLOOT OPENLOOT +8.94%
#6 Unit Pump Unit Pump +8.52%
#7 Pump.fun Pump.fun +8.52%
#8 Lorenzo Wrapped Bitcoin Lorenzo Wrapped Bitcoin +7.55%
#9 eCash eCash +7.18%
#10 Cash Cat Cash Cat +7.15%
Coin of the day
PulseChain PulseChain
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals, Inc.

MRNS
Classifica tra le azioni #28041
Marinus Pharmaceuticals, Inc. is a specialized biopharmaceutical firm dedicated... Marinus Pharmaceuticals, Inc. is a specialized biopharmaceutical firm dedicated to the development and commercialization of therapeutic solutions for individuals suffering from rare genetic epilepsies and other seizure-related conditions. The company's primary commercialized product is ZTALMY, an oral suspension specifically designed to manage seizures associated with cyclin-dependent kinase-like 5 deficiency disorder (CDD). This medication is prescribed for both adult and pediatric patient populations, suitable for use in acute and chronic care settings, and can be administered either in-patient or by the patient themselves. ZTALMY exerts its effect by targeting synaptic and extrasynaptic GABAA receptors, a mechanism that also suggests potential anticonvulsant, antidepressant, and anxiolytic benefits. Beyond ZTALMY, Marinus is actively progressing ganaxolone through development, an investigational therapy aimed at various genetic epileptic conditions such as PCDH19-related epilepsy, tuberous sclerosis complex, and Lennox-Gastaut Syndrome, with additional exploration for depressive disorders. The company maintains strategic alliances, including licensing agreements with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc., as well as a collaborative partnership with Orion Corporation. Marinus Pharmaceuticals was established in 2003 and operates from its corporate headquarters in Radnor, Pennsylvania.
Prezzo delle azioni
$0.55
Ultima sincronizzazione: 2025-02-11
Capitalizzazione di mercato
$28.90M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Marinus Pharmaceuticals, Inc. (MRNS)

Categoria

Healthcare
Il prezzo MRNS con la capitalizzazione del mercato della B
Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals, Inc.
MRNS
$0.55
Capitalizzazione di mercato di Marinus Pharmaceuticals, Inc.(MRNS)
Capitalizzazione di mercato: $28.90M
A partire dal August 2026, Marinus Pharmaceuticals, Inc. ha una capitalizzazione di mercato pari a $28.90M. Questo rende Marinus Pharmaceuticals, Inc. la 28041st azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Marinus Pharmaceuticals, Inc. dal 2014 al 2026
MRNS in paragone con la classifica dei più popolari stocks
Il prezzo per MRNS Attivo B Capitalizzazione del mercato a B Risultati
Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals, Inc.
$100,863 $28.90M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.301T +18,338,556.47%
Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals, Inc.
$88,171.23 $28.90M
Apple Inc. Apple Inc.
AAPL
$4.634T +16,031,032.11%
Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals, Inc.
$78,830.84 $28.90M
Alphabet Inc. Alphabet Inc.
GOOG
$4.143T +14,332,779.38%
Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals, Inc.
$68,297.02 $28.90M
Microsoft Corporation Microsoft Corporation
MSFT
$3.589T +12,417,540.68%
Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals, Inc.
$54,360.78 $28.90M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.857T +9,883,677.47%